Bloomia | 8-K: FY2026 Q3 Revenue: USD 14.44 M

Revenue: As of FY2026 Q3, the actual value is USD 14.44 M.

EPS: As of FY2026 Q3, the actual value is USD -0.43.

EBIT: As of FY2026 Q3, the actual value is USD -24 K.

Financial and Operational Metrics

Three Months Ended March 31, 2026

• Net Revenue: Bloomia Holdings, Inc. reported net revenue of $14.4 million, an increase from $12.4 million in the three months ended March 31, 2025.
• Gross Profit: Gross profit was $2.9 million, or 19.8% of sales, down from $3.9 million, or 31.3% of sales, in the prior year period.
• Operating Loss: The company recorded an operating loss of - $0.02 million, a decrease from an operating income of $1.4 million in the three months ended March 31, 2025.
• Net Loss from Continuing Operations: Net loss from continuing operations was - $0.8 million, compared to an income of $0.6 million in the same period last year.
• Net Loss Attributable to Bloomia Holdings, Inc.: Net loss attributable to Bloomia Holdings, Inc. was - $0.8 million, compared to net income of $0.4 million in the three months ended March 31, 2025.
• EBITDA: EBITDA for the quarter was $0.9 million, a reduction from $2.6 million in the three months ended March 31, 2025.

Nine Months Ended March 31, 2026

• Net Revenue: Net revenue increased to $26.3 million from $25.3 million in the nine months ended March 31, 2025.
• Gross Profit: Gross profit was $3.3 million, or 12.5% of sales, down from $4.7 million, or 18.8% of sales, in the comparable prior year period.
• Operating Loss: The operating loss expanded to - $5.4 million from - $3.8 million in the nine months ended March 31, 2025.
• Net Loss from Continuing Operations: Net loss from continuing operations was - $6.8 million, compared to a loss of - $4.2 million in the nine months ended March 31, 2025.
• Net Loss Attributable to Bloomia Holdings, Inc.: Net loss attributable to Bloomia Holdings, Inc. was - $5.9 million, compared to a net loss of - $3.6 million in the nine months ended March 31, 2025.
• EBITDA: EBITDA was a loss of - $2.9 million, compared to a loss of - $0.7 million in the nine months ended March 31, 2025.

Cash Flow

• Cash Used in Operations: Cash used in operations for the nine months ended March 31, 2026, was - $11.1 million, an increase from - $7.3 million in the prior year period.

Balance Sheet Highlights (as of March 31, 2026 vs. June 30, 2025)

• Cash and Cash Equivalents: Cash and cash equivalents totaled $0.9 million, largely consistent with $0.9 million at June 30, 2025.
• Working Capital: Working capital significantly increased to $4.8 million from $1.1 million at June 30, 2025, primarily due to higher receivables from Easter sales.
• Total Assets: Total assets were $103.3 million, up from $97.9 million at June 30, 2025.
• Total Debt: Total debt rose to $47.5 million from $34.1 million at June 30, 2025, due to drawing on its revolving line of credit and borrowing for tulip bulb purchases.
• Total Liabilities: Total liabilities increased to $95.5 million from $83.1 million at June 30, 2025.
• Stockholders’ Equity: Stockholders’ equity was $7.8 million, down from $14.8 million at June 30, 2025.

Unique Financial Events

• Rights Offering: Bloomia Holdings, Inc. completed a rights offering, generating gross proceeds of $12.1 million, comprising $5.0 million in cash and $7.1 million from the conversion of outstanding debt. Approximately 3,000,000 shares were issued at $4.05 per share, and the net cash proceeds were used to make a $4.9 million long-term debt payment, which resulted in approximately $10.0 million in debt forgiveness.

Outlook

Bloomia Holdings, Inc. anticipates a strong fourth quarter driven by increased stem availability and historically higher demand. The company expects a more profitable fiscal year 2027 as challenges from rising raw material costs, tariffs, and a strengthening Euro are resolving. The recent rights offering and debt paydown are also noted to position the company for future growth.